TOLEDO, OHIO and MADRID, SPAIN — MARCH 21, 2022 NAMSA, a world leading MedTech Contract Research Organization (CRO) offering global end-to-end
On 28 January 2022, Regulation 2022/112 entered into force, amending the transitional provisions in Article 110 of the (EU) 2017/746. As a result,
In vitro diagnostic medical devices (IVDs) are increasingly in demand as the medical technology evolves by leaps and bounds. With the application of
Acquisition to Enhance Cardiovascular Expertise and Regional Presence in Europe TOLEDO, OHIO and MADRID, SPAIN — MARCH 21, 2022 NAMSA, a
Performance studies for SARS-CoV-2 IVD tests have become a hot topic since the publication of the MDCG 2021-21 and the common list of COVID-19 IVD
In-vitro diagnostic tests for detecting the coronavirus is an essential tool in slowing the
Checkout our LinkedIn profile.
Checkout our selection of resources about medical devices and clinical writing.
AKRN Social Network